BioSpace News Archive

miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced it will report its fourth quarter and full year 2019 financial results after the financial markets close on Wednesday, March 11, 2020.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, plans to report fourth quarter 2019 financial results on Thursday, February 27, 2020, after the close of U.S. markets.

resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today announced that the company will present at the 9th Annual Leerink Partners Global Healthcare Conference in New York City on Thursday, February 27, 2019 at 10:00 AM ET.